N-1-carboxyalkyl derivatives of LSD
AssigneeBoehringer Mannheim GmbH
InventorsGerald F. Sigler, Riaz Rouhani, David Davoudzaheh
Life of this patent
Estimating the term…
Loading patent…
AssigneeBoehringer Mannheim GmbH
InventorsGerald F. Sigler, Riaz Rouhani, David Davoudzaheh
Estimating the term…
Novel derivatives of LSD having the formula ##STR1## wherein R.sub.1 is an alkyl, cycloalkyl or aryl group having 1 to 10 carbon atoms, preferably an alkyl group having 1 carbon atom; R.sub.2 is a bond or ##STR2## wherein R.sub.3 is alkyl, cycloalkyl or aryl group having 2 to 10 carbon atoms, preferably an alkyl group having 2 or 5 carbon atoms; Z is an immunogenic carrier substance, an enzyme donor polypeptide or a label selected from the group consisting of an enzyme, a substance having fluorescent or luminescent properties and a radioactive substance; and n is 1 to p where p equals MW of Z/1000. The derivatives include maleimide conjugates of an immunogenic poly(amino acid), an enzyme donor polypeptide or a labeling substance such as an enzyme, a fluorescent substance or a radioactive substance. Novel activated hapten intermediates useful in the preparation of the conjugates and methods for synthesis of the hapten intermediates and their conjugate derivatives are also disclosed.
An enzyme immunoassay method for determining LSD in a sample comprising:
An enzyme immunoassay method for determining LSD in a sample comprising:
A set of reagents for determining the presence of LSD or its metabolites in a urine sample by enzyme immunoassay, comprising:
An enzyme immunoassay method for determining the presence of LSD or LSD metabolites in a sample, comprising
Dependencies are inferred from the claim text.